Lv2
190 积分 2024-04-07 加入
Abstract 3139: BL-M11D1, a novel CD33-targeting ADC, demonstrates robust anti-tumor efficacy in preclinical evaluation
2天前
求助中
First Disclosure of AZD9829, a TOP1i-ADC Targeting CD123: Promising Preclinical Activity in AML Models with Minimal Effect on Healthy Progenitors
2天前
已完结
Mechanisms of substrate processing during ER-associated protein degradation
1个月前
已完结
Intermittent fasting triggers interorgan communication to suppress hair follicle regeneration
6个月前
已完结
Anti‐Tumor Immunity Induced by a Ternary Membrane System Derived From Cancer Cells, Dendritic Cells, and Bacteria
6个月前
已完结
A neoantigen vaccine generates antitumour immunity in renal cell carcinoma
6个月前
已完结
Neoadjuvant palbociclib plus either giredestrant or anastrozole in oestrogen receptor-positive, HER2-negative, early breast cancer (coopERA Breast Cancer): an open-label, randomised, controlled, phase 2 study
7个月前
已完结
The winding road: Infectious disease considerations for CAR-T and other novel adoptive cellular therapies in the era of COVID-19
9个月前
已完结
Intracellular checkpoints for NK cell cancer immunotherapy
9个月前
已完结
Interfering with KIR and NKG2A immune checkpoint axes to unleash NK cell immunotherapy
9个月前
已完结
皖公网安备34019202002308
